International Flavors & Fragrances (IFF) FY2025 10-K Annual Report

Filed: Feb 27, 2026
Health Care
Industrial Organic ChemicalsSEC EDGAR

International Flavors & Fragrances (IFF) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 27, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

International Flavors & Fragrances FY2025 10-K Analysis

Business Overview

  • Core model: leading creator/manufacturer of flavors, food ingredients, biotechnology-derived ingredients (enzymes, cultures, probiotics), and scents; $10.89B FY2025 sales
  • Structural change: former Nourish segment split into two new segments — Taste and Food Ingredients — effective January 1, 2025
  • Portfolio divestiture: Pharma Solutions segment fully exited via two divestitures completed May 1 and May 9, 2025, narrowing focus to four core segments
  • ~21,500 employees globally as of December 31, 2025, with ~3,000 dedicated to R&D; U.S. represents 28% of sales, no single country exceeds 10%
  • EcoVadis Gold sustainability rating placing IFF in top 5% of assessed companies; CDP Climate A-list designation for tenth time since 2015

Management Discussion & Analysis

  • Revenue $10.89B in 2025, down 5% reported vs $11.484B in 2024; comparable currency neutral basis up 2%, with ~$757M drag from divestitures
  • Gross margin 36.2% vs 35.9% in 2024; operating margin swung to -3.5% vs 6.7% in 2024, driven by $1.153B Food Ingredients goodwill impairment
  • Best segment: Health & Biosciences, EBITDA margin 26.7% vs 26.2%; worst: Food Ingredients, sales -3% and $1.153B goodwill impairment recorded
  • Operating cash flow $850M (7.8% of sales) vs $1.07B in 2024; $2.0B Senior Notes repurchased; dividends $409M ($1.60/share); buybacks $38M; capex guided ~6% of sales in 2026
  • Key risks: ongoing Food Ingredients division sale process, tariffs/trade disruptions, FX exposure, Health & Biosciences goodwill headroom thin at 9% above carrying value

Risk Factors

  • Antitrust investigations ongoing in multiple countries + class action lawsuits in U.S. and Canada; enforcement could bring significant fines and business restrictions
  • Total debt ~$5.994B as of Dec 31, 2025; dividend cut ~50% in Feb 2024 to accelerate deleveraging
  • Goodwill impairment charge of $1.153B recorded in Food Ingredients segment following 2025 segment restructuring; $14.3B intangible assets/goodwill remain at risk
  • Reliance on limited suppliers/regions for essential oils, botanical extracts, and petroleum-based chemicals; tariffs, U.S.-China tensions, and Russia-Ukraine war strain margins
  • ~72% of 2025 net sales outside U.S.; currency volatility and OECD Pillar Two 15% minimum tax (applicable to IFF given scale) add cross-border tax and FX exposure

International Flavors & Fragrances FY2025 Key Financial Metrics
XBRL

Revenue

$10.9B

-5.2% YoY

Net Income

-$361M

-248.6% YoY

Gross Margin

36.2%

+25bp YoY

Operating Margin

-3.5%

-1018bp YoY

Net Margin

-3.3%

-543bp YoY

ROE

-2.6%

-430bp YoY

Total Assets

$25.5B

-10.9% YoY

EPS (Diluted)

$-1.41

-248.4% YoY

Operating Cash Flow

$850M

-20.6% YoY

Source: XBRL data from International Flavors & Fragrances FY2025 10-K filing on SEC EDGAR. All figures in USD.

Other International Flavors & Fragrances Annual Reports

Get deeper insights on International Flavors & Fragrances

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.